185 related articles for article (PubMed ID: 24123094)
1. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Tormey W; Smith D; Thompson CJ; McKenna MJ; Agha A
Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
[TBL] [Abstract][Full Text] [Related]
2. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.
Behan LA; Carmody D; Rogers B; Hannon MJ; Davenport C; Tormey W; Smith D; Thompson CJ; Stanton A; Agha A
Eur J Endocrinol; 2016 Jun; 174(6):791-9. PubMed ID: 27025241
[TBL] [Abstract][Full Text] [Related]
3. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
Dineen R; Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Keevil BG; Tormey W; Smith D; Thompson CJ; McKenna MJ; Arlt W; Stewart PM; Agha A; Sherlock M
BMC Endocr Disord; 2020 Oct; 20(1):154. PubMed ID: 33036588
[TBL] [Abstract][Full Text] [Related]
4. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.
Behan LA; Rogers B; Hannon MJ; O'Kelly P; Tormey W; Smith D; Thompson CJ; Agha A
Clin Endocrinol (Oxf); 2011 Oct; 75(4):505-13. PubMed ID: 21521342
[TBL] [Abstract][Full Text] [Related]
5. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
[TBL] [Abstract][Full Text] [Related]
6. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
[TBL] [Abstract][Full Text] [Related]
7. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
Peacey SR; Wright D; Aye M; Moisey R
Clin Endocrinol (Oxf); 2012 Jul; 77(1):94-8. PubMed ID: 22151005
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy.
Zimmermann A; Sido PG; Schulze E; Al Khzouz C; Lazea C; Coldea C; Weber MM
Clin Endocrinol (Oxf); 2009 Oct; 71(4):477-84. PubMed ID: 19170706
[TBL] [Abstract][Full Text] [Related]
11. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
Glover SJ; Eastell R; McCloskey EV; Rogers A; Garnero P; Lowery J; Belleli R; Wright TM; John MR
Bone; 2009 Dec; 45(6):1053-8. PubMed ID: 19679211
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
13. Acute response of plasma markers of bone turnover to a single bout of resistance training or plyometrics.
Rogers RS; Dawson AW; Wang Z; Thyfault JP; Hinton PS
J Appl Physiol (1985); 2011 Nov; 111(5):1353-60. PubMed ID: 21868687
[TBL] [Abstract][Full Text] [Related]
14. [Short-term effects of citrate on markers of bone metabolism in Chinese blood donor volunteers].
Chu XL; Hou JM; Lin H; Lin HK; Zeng J; Chen GL; Chen C; Lin J; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):785-9. PubMed ID: 20561451
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of sex hormones and parathyroid hormone with biochemical markers of bone turnover in aged men].
Xiao HY; Lu YH; Gong YP; Pei Y; Cheng XL; Li N; Fang FS; Tian H; Li CL
Zhonghua Nan Ke Xue; 2014 Mar; 20(3):257-62. PubMed ID: 24738465
[TBL] [Abstract][Full Text] [Related]
16. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.
Sherlock M; Behan LA; Hannon MJ; Alonso AA; Thompson CJ; Murray RD; Crabtree N; Hughes BA; Arlt W; Agha A; Toogood AA; Stewart PM
Eur J Endocrinol; 2015 Nov; 173(5):583-93. PubMed ID: 26264718
[TBL] [Abstract][Full Text] [Related]
17. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
Petersons CJ; Mangelsdorf BL; Thompson CH; Burt MG
J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.
Dunne FP; Elliot P; Gammage MD; Stallard T; Ryan T; Sheppard MC; Stewart PM
Clin Endocrinol (Oxf); 1995 Nov; 43(5):623-9. PubMed ID: 8548948
[TBL] [Abstract][Full Text] [Related]
20. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
